All In MedTech

Device Trial Radar · NCT07356089

Twiist Postmarket Surveillance Study for Type 1 Diabetes

Twiist Postmarket Surveillance Study in Adults and Youth With Type 1 Diabetes

Last checked: Nov 19, 2026Latest source record: Jan 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,875

Planned (sponsor's estimate)

Start

Dec 9, 2025

Primary completion

May 1, 2027

Study completion May 1, 2028

Sponsor

Lead sponsor
Deka Research and DevelopmentNot on our public-company list
Sponsor type
Industry
Collaborators
Jaeb Center for Health Research
First posted
Jan 21, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.

Conditions

  • Type 1 Diabetes (T1D)
  • Type 1 Diabetes Mellitus

Interventions

  • twiist Automated Insulin Delivery SystemDevice

    twiist(TM) system includes a novel insulin pump, a CGM sensor, and the glycemic-control algorithm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Severe hypoglycemia eventsTime frame: From enrollment to the end of participation at 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jaeb Center for Health Research

    Tampa, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.